⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Genfarma Joint Stock Company and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Genfarma Joint Stock Company
↗Hanoi, Vietnam
Genfarma is a high-tech biopharmaceutical joint venture established between BioCubaFarma (Cuba) and Genfarma Holdings (Vietnam). The company focuses on the research, development, and production of high-tech biopharmaceuticals, with a specific emphasis on oncology, immunology, neurology, and hematology.
The company operates a state-of-the-art manufacturing facility located in the Hoa Lac High-Tech Park in Hanoi, Vietnam. Its mission is to improve pharmaceutical security in Vietnam by leveraging technology transfers from Cuba's advanced biotechnology sector to produce high-quality, accessible medications for the Asian market.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2025
Ownership:private
Status:operating
FUNDING
Investors:BioCubaFarma, Genfarma Holdings
PIPELINE
Stage:Commercial
Lead Drug Stage:Technology transfer/Production
Modalities:Biopharmaceuticals, Recombinant proteins
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:BioCubaFarma (Technology transfer partner), Vietnam Academy of Science and Technology (VAST) (Research collaboration), FPT (Digital transformation partner)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Bui Le Khoa - CEO
Manuel Enrique Montané Enriquez - Director of Operations and Technology
Vladimir Peňa Sánchez - Head of Quality Control Department
LINKS
Website:genfarma.vn
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Genfarma Joint Stock Company. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.